Precision Genomics Laboratory

The Department of Pathology and Cell Biology and the Institute for Genomic Medicine (IGM) have formed the Precision Genomics Laboratory (PGL), a new joint initiative designed to enhance patient care through genomic diagnostics, research, and education at Columbia University Medical Center.

The PGL will combine next-generation sequencing in a certified clinical laboratory (CLIA and CAP-accredited) to provide patients, families, and physicians with unprecedented information with which to make informed health decisions. The PGL enhances the University-wide, interdisciplinary, Precision Medicine Initiative by offering unique training opportunities and new avenues for novel diagnostic genomics test development. The overarching mission of the PGL is to apply advanced genomic science in a clinically actionable setting to improve the diagnosis and treatment of human disease.

Genetic Testing:

• Columbia Diagnostic Exome (CDEX)
• Columbia Preventive Genomic Screen
• Cystic Fibrosis Screening
• Sanger Sequencing of Individual Variants

Related News:

• Meet Anya Revah Politi, a genetic counselor in the Institute for Genomic Medicine and the Precision Genomics Laboratory, featured on P&S social media accounts: Facebook and Twitter.
• Study Reveals Genomics Sometimes See What Other Tests Can’t in Prenatal Testing - Path News
• CUIMC Announces New Partnership with Fulgent Genetics - Path News